Michael P. Porter

4.6k total citations
64 papers, 2.5k citations indexed

About

Michael P. Porter is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Michael P. Porter has authored 64 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 23 papers in Pulmonary and Respiratory Medicine and 15 papers in Urology. Recurrent topics in Michael P. Porter's work include Bladder and Urothelial Cancer Treatments (33 papers), Urinary and Genital Oncology Studies (27 papers) and Prostate Cancer Treatment and Research (12 papers). Michael P. Porter is often cited by papers focused on Bladder and Urothelial Cancer Treatments (33 papers), Urinary and Genital Oncology Studies (27 papers) and Prostate Cancer Treatment and Research (12 papers). Michael P. Porter collaborates with scholars based in United States, Canada and South Africa. Michael P. Porter's co-authors include Jonathan L. Wright, Daniel W. Lin, David F. Penson, Paul H. Lange, Mia A. Swartz, Noel S. Weiss, Janet L. Stanford, Alan M. Nieder, John L. Gore and Mark S. Soloway and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Cancer.

In The Last Decade

Michael P. Porter

62 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Porter United States	27	1.6k	813	669	604	242	64	2.5k
Stephan Roth Germany	25	1.2k 0.8×	635 0.8×	452 0.7×	400 0.7×	180 0.7×	150	2.1k
Kenneth G. Nepple United States	25	1.1k 0.7×	471 0.6×	566 0.8×	317 0.5×	346 1.4×	109	2.1k
Alchiede Simonato Italy	30	1.1k 0.7×	798 1.0×	799 1.2×	544 0.9×	390 1.6×	137	2.4k
Rodney Davis United States	33	1.4k 0.9×	642 0.8×	1.2k 1.8×	389 0.6×	417 1.7×	91	2.8k
Hans‐Martin Fritsche Germany	26	1.9k 1.2×	791 1.0×	500 0.7×	360 0.6×	135 0.6×	90	2.4k
Kinjal Vora United States	15	1.8k 1.1×	867 1.1×	916 1.4×	463 0.8×	120 0.5×	30	2.6k
Rodolphe Thuret France	27	1.0k 0.7×	359 0.4×	1.3k 1.9×	458 0.8×	479 2.0×	109	2.2k
Florian Roghmann Germany	26	936 0.6×	351 0.4×	804 1.2×	352 0.6×	298 1.2×	115	1.9k
Ilias Cagiannos Canada	30	1.2k 0.8×	490 0.6×	1.4k 2.1×	362 0.6×	247 1.0×	120	2.6k
M. Roumiguié France	25	1.3k 0.8×	443 0.5×	1.2k 1.7×	431 0.7×	334 1.4×	199	2.5k

Countries citing papers authored by Michael P. Porter

Since Specialization

Citations

This map shows the geographic impact of Michael P. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Porter more than expected).

Fields of papers citing papers by Michael P. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Porter. The network helps show where Michael P. Porter may publish in the future.

Co-authorship network of co-authors of Michael P. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Porter. A scholar is included among the top collaborators of Michael P. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Porter. Michael P. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sorensen, Mathew D., Barbrina Dunmire, Jeff Thiel, et al.. (2024). Randomized Controlled Trial of Ultrasonic Propulsion–Facilitated Clearance of Residual Kidney Stone Fragments vs Observation. The Journal of Urology. 212(6). 811–820. 2 indexed citations

Wright, Jonathan L., Jeannette M. Schenk, Roman Gulati, et al.. (2024). The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance. Cancer. 130(12). 2108–2119. 3 indexed citations

Macleod, Liam C., Steven B. Zeliadt, Sarah K. Holt, et al.. (2015). Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort. Prostate Cancer and Prostatic Diseases. 18(2). 190–195. 19 indexed citations

James, Andrew, Jason Izard, William Proctor Harris, et al.. (2014). Role of Maximal Endoscopic Resection Before Cystectomy for Invasive Urothelial Bladder Cancer. Clinical Genitourinary Cancer. 12(4). 287–291. 18 indexed citations

James, Andrew, Sarah K. Holt, Jonathan L. Wright, Michael P. Porter, & John L. Gore. (2014). Burden and timing of venothrombolic events in patients younger than 65 years undergoing radical cystectomy for bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(6). 815–819. 13 indexed citations

Chen, Yiyi, Tracy M. Downs, Bernard H. Bochner, et al.. (2014). Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions. Advances in Urology. 2014. 1–6. 41 indexed citations

Weiser, Thomas G., Michael P. Porter, & Ronald V. Maier. (2013). Safety in the operating theatre—a transition to systems-based care. Nature Reviews Urology. 10(3). 161–173. 7 indexed citations

Mossanen, Matthew, Heather H. Cheng, William Proctor Harris, et al.. (2013). Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder. Clinical Genitourinary Cancer. 12(3). 210–213. 10 indexed citations

Wright, Jonathan L., William Proctor Harris, Heather H. Cheng, et al.. (2013). Pathologic response rates between gemcitabine-cisplatin (GC) and methotrexate, vinblastine, doxorubicin hydrochloride, and cisplatin (MVAC) neoadjuvant chemotherapy in muscle-invasive urothelial cell carcinoma of the bladder.. Journal of Clinical Oncology. 31(6_suppl). 267–267. 1 indexed citations

10.

Grant, Eric J., Kotaro Ozasa, Dale L. Preston, et al.. (2012). Effects of Radiation and Lifestyle Factors on Risks of Urothelial Carcinoma in the Life Span Study of Atomic Bomb Survivors. Radiation Research. 178(1). 86–98. 18 indexed citations

11.

Cooperberg, Matthew R., Michael P. Porter, & Badrinath R. Konety. (2009). Candidate quality of care indicators for localized bladder cancer. Urologic Oncology Seminars and Original Investigations. 27(4). 435–442. 31 indexed citations

12.

Lotan, Yair, Ashish M. Kamat, Michael P. Porter, et al.. (2009). Key concerns about the current state of bladder cancer. Cancer. 115(18). 4096–4103. 52 indexed citations

13.

Porter, Michael P., et al.. (2009). Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urologic Oncology Seminars and Original Investigations. 29(3). 252–258. 103 indexed citations

14.

Nieder, Alan M., Michael P. Porter, & Mark S. Soloway. (2008). Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study. The Journal of Urology. 180(5). 2005–2010. 133 indexed citations

15.

Porter, Michael P. & Daniel W. Lin. (2007). Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States. Urologic Oncology Seminars and Original Investigations. 25(4). 298–302. 43 indexed citations

16.

Swartz, Mia A., Mona T. Lydon‐Rochelle, David Simón, Jonathan L. Wright, & Michael P. Porter. (2007). Admission for Nephrolithiasis in Pregnancy and Risk of Adverse Birth Outcomes. Obstetrics and Gynecology. 109(5). 1099–1104. 79 indexed citations

17.

Dall’Era, Marc, et al.. (2007). Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urology. 7(1). 3–3. 53 indexed citations

18.

Swartz, Mia A., Michael P. Porter, Daniel W. Lin, & Noel S. Weiss. (2006). Incidence of primary urethral carcinoma in the United States. Urology. 68(6). 1164–1168. 144 indexed citations

19.

Wright, Jonathan L., Michael P. Porter, Christopher I. Li, Paul H. Lange, & Daniel Lin. (2006). Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer. 107(4). 721–728. 136 indexed citations

20.

Porter, Michael P. & Paul H. Lange. (2005). Controversies in the Surgical Management of Renal Cancer. Journal of the National Comprehensive Cancer Network. 3(1). 95–102. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact